News and Analysis | Published:

Anti-ageing pipeline starts to mature

Nature Reviews Drug Discovery volume 17, pages 609612 (2018) | Download Citation

Ongoing and upcoming clinical trials of metformin, mTOR inhibitors and senescent cell-killing drugs could prove that ageing and ageing-related diseases are viable drug discovery indications.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

About this article

Publication history




  1. Search for Asher Mullard in:

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing